Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

902 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan.
Ogawa Y, Yokoi H, Ohki T, Kichikawa K, Nakamura M, Komori K, Nanto S, O'Leary EE, Lottes AE, Saunders AT, Dake MD. Ogawa Y, et al. Cardiovasc Intervent Radiol. 2017 Nov;40(11):1669-1677. doi: 10.1007/s00270-017-1673-6. Epub 2017 May 9. Cardiovasc Intervent Radiol. 2017. PMID: 28488101 Free PMC article.
Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels-Results from the Zilver PTX Japan Post-Market Surveillance Study.
Cipollari S, Yokoi H, Ohki T, Kichikawa K, Nakamura M, Komori K, Nanto S, O'Leary EE, Lottes AE, Saunders AT, Dake MD. Cipollari S, et al. J Vasc Interv Radiol. 2018 Jan;29(1):9-17.e1. doi: 10.1016/j.jvir.2017.08.014. Epub 2017 Nov 7. J Vasc Interv Radiol. 2018. PMID: 29122449 Free article.
Using the Evaluating Devices Using Claims and RegisTry Data (EDUCATe) Plan within the Vascular Implant Surveillance and Interventional Outcomes Network (VISION) to Analyze the Long-Term Outcomes following Endovascular Aortic Aneurysm Repair.
Suckow BD, Mao J, Williams S, Saunders A, Flores AMT, Eid MT, Moore K, Hoel A, Eldrup-Jorgensen J, Sedrakyan A, Goodney PP. Suckow BD, et al. Among authors: saunders a. Ann Vasc Surg. 2023 Mar;90:85-92. doi: 10.1016/j.avsg.2022.10.015. Epub 2022 Nov 19. Ann Vasc Surg. 2023. PMID: 36410641
Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices.
Dake MD, Ansel GM, Bosiers M, Holden A, Iida O, Jaff MR, Lottes AE, O'Leary EE, Saunders AT, Schermerhorn M, Yokoi H, Zeller T. Dake MD, et al. Among authors: saunders at. Cardiovasc Intervent Radiol. 2020 Jan;43(1):8-19. doi: 10.1007/s00270-019-02324-4. Epub 2019 Sep 9. Cardiovasc Intervent Radiol. 2020. PMID: 31502026 Free PMC article. Clinical Trial.
Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study).
Hofmann LR, Gagne P, Brown JA, Saunders A, Comerota A; VIVO Study Investigators. Hofmann LR, et al. Among authors: saunders a. J Vasc Surg Venous Lymphat Disord. 2023 May;11(3):532-541.e4. doi: 10.1016/j.jvsv.2022.12.066. Epub 2023 Jan 13. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36646383 Free article. Clinical Trial.
902 results